Intellikine
La Jolla, California, United States
About Intellikine
Intellikine works in the discovery and development of novel, small molecule therapies targeting the PI3K/Akt/mTOR pathway. Intellikine is committed to building an exceptional team and a powerful discovery platform that rapidly generates small molecule kinase inhibitor drug candidates that will become the next generation of medical breakthroughs.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $85.0M
- Funding stage: M&A
- Last round: Series Unknown (Oct 2011)
- Website: intellikine.com
- Phone: +1 858-768-6500
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/intellikine-2607948 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.